Seeing Is Believing
Healthcare - Sector
SPRB is currently covered by 5 analysts with an average price target of $168.5. This is a potential upside of $123.95 (278.23%) from yesterday's end of day stock price of $44.55.
Spruce Biosciences's activity chart (see below) currently has 2 price targets and 21 ratings on display. The stock rating distribution of SPRB is 93.33% BUY and 6.67% HOLD.
Highest price target for SPRB is $230, Lowest price target is $104, average price target is $168.5.
Most recent stock forecast was given by JONATHAN WOLLEBEN from JMP on 24-Sep-2026. First documented stock forecast 03-Nov-2020.
Currently out of the existing stock ratings of SPRB, 14 are a BUY (93.33%), 1 are a HOLD (6.67%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 11-Nov-2025
$144
$97.61 (210.41%)
$144
1 months 9 days ago
(24-Sep-2026)
0/7 (0%)
$94.98 (193.76%)
Buy Since 16-Jun-2026
$104
$57.61 (124.19%)
$123
2 months 16 days ago
(17-Aug-2026)
0/2 (0%)
$51.08 (96.52%)
Buy Since 23-Dec-2025
$230
$183.61 (395.80%)
$283
5 months 6 days ago
(27-May-2026)
0/2 (0%)
$180.48 (364.46%)
Buy Since 22-Dec-2025
$200
$153.61 (331.13%)
$200
7 months 23 days ago
(10-Mar-2026)
0/3 (0%)
$137.21 (218.52%)
Hold Since 21-Oct-2025
$160
$113.61 (244.90%)
$160
10 months 30 days ago
(03-Dec-2025)
0/3 (0%)
$69.84 (77.46%)
Which analyst most recently updated their price target on SPRB (Spruce Biosciences)?
Which analyst has the most public recommendations on SPRB (Spruce Biosciences)?
Which analyst is the currently most bullish on SPRB (Spruce Biosciences)?
Which analyst is the currently most reserved on SPRB (Spruce Biosciences)?